China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multicenter Study on the Impact of Rapid Diagnostic Tests (RDTs) on Treatment Patterns and Clinical Outcomes in Patients with Carbapenem-Resistant Organism (CRO) Infections'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132207

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342804

Published by HT Digital Content Services with permission from Health Daily Digest....